Eurocom Investments

Eurocom Investments was the private equity and investment arm of the Eurocom Group, a major Israeli holding company formerly controlled by Shaul Elovitch. The firm focused significantly on the life sciences and medical technology sectors, managing a portfolio that included prominent healthcare companies such as Medinol, a leader in cardiovascular stent technology. Eurocom Investments played a key role in the Israeli high-tech and med-tech ecosystem, providing capital and strategic oversight to development-stage companies. Following the financial collapse of the broader Eurocom Group, the investment entity entered liquidation proceedings in the late 2010s. Its legacy remains tied to its early support of innovative medical device and biopharmaceutical ventures in Israel.